ReviewDrug design, development and therapy2021

An Update Review of Biosimilars of Adalimumab in Psoriasis - Bioequivalence and Interchangeability.

Xin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.